Our patients, our priority
Putting our patients first is what allowed Khiron Life Sciences to become the medical cannabis market leader in Latin America.
Our Goal in UK
Khiron Life Sciences UK was founded in October 2019 and has been working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.
Our team
Our team is composed of experienced professionals from of the European medical cannabis industry. We are working closely with the London-based leading independent scientific body, Drug Science, responsible for Project Twenty21, the largest medical cannabis patient registry in Europe.
Our patients, our priority
Putting our patients first is what allowed Khiron Life Sciences to become the medical cannabis market leader in Latin America.
Our Goal in UK
Khiron Life Sciences UK was founded in October 2019 and has been working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.
Our team
Our team is composed of experienced professionals from of the European medical cannabis industry. We are working closely with the London-based leading independent scientific body, Drug Science, responsible for Project Twenty21, the largest medical cannabis patient registry in Europe.
Management
Meet our Management-Team
Franziska Katterbach
President, Europe
Frederic Lammer
Director of Operations, Europe
Dr. Guillermo Moreno-Sanz
Global Scientific Director